Tigermed Expands Clinical Trial Capabilities With Oracle Health Sciences InForm

 Hangzhou Tigermed Consulting Co., Ltd, a leading clinical contract
            research organization (CRO) in China, recently selected Oracle Health
            Sciences InForm to more efficiently develop, conduct and manage
            electronic data capture (EDC)-based clinical trials on behalf of its
        --  Being an existing user of Oracle Clinical for their paper trials,
            Tigermed selected Oracle Health Sciences InForm to extend its
            competitive edge in the local market and support international
            expansion with a trusted and highly scalable, leading clinical data
            management platform.
        --  With its standardized feature sets, comprehensive data capture
            functionality and multi-language capabilities, Oracle Health Sciences
            InForm provides Tigermed with a robust solution to meet the needs of
            China's clinical trial sponsors -- while allowing for seamless
            expansion into the global marketplace.
        --  Oracle Health Sciences InForm's comprehensive data review capabilities
            will enable Tigermed to gain better control over its data and generate
            efficiency and productivity gains in data management and remote
        --  Using Oracle Health Sciences InForm, Tigermed will be able to develop
            flexible source verification strategies that allow rapid changes to
            the source verification workload based on data quality.
        --  In addition, Tigermed will be able to take advantage of Oracle Health
            Sciences Central Designer's centralized study design environment to
            accelerate trial development and increase trial efficiency.
        --  To differentiate its business and gain a competitive advantage,
            Tigermed joined the Oracle CRO Advantage Program -- a program that
            provides a framework for driving CRO success with Oracle Health
            Sciences products through training, sales and marketing support and
            tools and regular communications on Oracle products and strategy.

Supporting Quotes

        --  "By adopting Oracle Health Sciences InForm, we will be positioned to
            support the growing number of clinical trials conducted in China, and
            their sponsors, with leading clinical data management capabilities,"
            said Wen Chen, vice president, Tigermed. "Further, with Oracle's
            training and support through the Oracle CRO Advantage Program, we can
            maximize our investment in Oracle Health Sciences solutions --
            securing the confidence of a growing number of clinical trial
        --  "With a heavy focus on growth, Tigermed requires a solution that will
            extend its clinical data management and EDC capabilities," said Neil
            de Crescenzo, senior vice president and general manager, Oracle Health
            Sciences. "Tigermed relies on Oracle Health Sciences' world-class
            solutions, including Oracle Health Sciences InForm and Oracle Health
            Sciences Central Designer, to enable rapid trial set up, data
            accuracy, clinical trial productivity and informed decision making --
            helping Tigermed to gain the trust of both local and global trial

Supporting Resources


        --  Oracle in Health Sciences
        --  Oracle Health Sciences InForm
        --  Oracle Clinical
        --  Oracle Health Sciences Central Designer
        --  Follow Oracle Health Sciences on Twitter
        --  Join the Oracle Health Sciences Community on Facebook
        --  Oracle Health Sciences on YouTube

About Oracle Oracle engineers hardware and software to work together in the cloud and in your data center. For more information about Oracle ORCL -0.14%  , visit www.oracle.com .

About Oracle in Industries Oracle industry solutions leverage the company's best-in-class portfolio of products to address complex business processes relevant to health sciences, helping speed time to market, reduce costs, and gain a competitive edge.


Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

About Tigermed Hangzhou Tigermed Consulting Co., Ltd is a leading full service clinical stage Contract Research Organization (CRO) in China. For more information about Tigermed (ChiNext 300347), visit www.tigermed.net

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.